Michael (Mike) A. Applebaum

Michael (Mike) A. Applebaum

Counsel, New York

Mike Applebaum counsels clients on a broad range of executive compensation and employee benefits matters. He advises clients on the compensation and benefits aspects of corporate transactions (both public and private) and on various tax, securities law, and corporate governance matters pertaining to executive compensation.

Mike helps clients design, draft, negotiate, and administer a wide array of compensation related arrangements, including consulting, employment, retention and separation agreements, cash and equity-based incentive plans and award agreements, severance plans, and deferred compensation arrangements. He regularly advises clients on compensation and benefits issues that arise throughout the life cycle of various types of corporate transactions, including mergers, acquisitions, divestitures, spin-offs, and initial public offerings. Mike also assists public company clients with their SEC disclosure obligations related to executive compensation matters.

Education and admissions

Education

J.D., George Washington University Law School, with honors, 2008

B.S. Business Administration, Washington University in St. Louis, 2001

Bar admissions and qualifications

New York

Representative experience

Represented 21st Century Fox on its formation of National Geographic Partners with The National Geographic Society.

Represented Lockheed Martin Corporation on the combination of its IT and Technical Services businesses with Leidos in a US$5.0bn Reverse Morris Trust transaction.

Represented Ford Motor Company in connection with its acquisition of Chariot Transit, Inc.

Represented Landmark Apartment Trust, Inc. in its US$1.9bn acquisition by an affiliate of Starwood Capital Group and Milestone Apartments REIT.

Represented Dupont Fabros Technology in its US$7.6bn merger with Digital Realty.

Represented Valeant on the sale of Dendreon Pharmaceuticals, Inc. to the Sanpower Group Co., Ltd for US$820m.

Represented Laboratory Corporation of America in its acquisitions of Chiltern and Sequenom.

Represented General Electric Capital in the US$9bn sale of its health care financial services business to Capital One.

Loading data